Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Recruiting Phase 4 Interventional Study
Smoke Exposure Influenza
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 49
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Basic Science
Participants needed
112 (estimated)
Sponsor
University of North Carolina, Chapel Hill · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will investigate the effects of woodsmoke (WS) exposure on human nasal mucosal immune responses to viral infection. The study tests the hypotheses that WS exposure modifies biomarkers of nasal mucosal immune function, increases in Live Attenuated Influenza Virus (LAIV) -induced nasal symptoms, and reduces mucosal antibody production.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Normal lung function, * oxygen saturation of \>94%, * normal blood pressure, * no respiratory symptoms on history, no abnormalities on exam, normal pulmonary function testing, * 18-49 Years of age. Exclusion Criteria: * A history of significant chronic illnesses (to include …
Contacts

Carole Robinette, MS

919 966-5638

carole_robinette@med.unc.edu

CONTACT

Chris Brooks

chris_brooks@med.unc.edu

CONTACT